Publication | Closed Access

Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateMedicinePharmaceutical NanotechnologySequential ReleaseBreast CancerNano-drug DeliveryTumor TargetingPlga-casein Core/shell NanoparticlesPharmacologyRadiation OncologyEpigallocatechin Gallate